Gill Livingston | |
---|---|
Alma mater | University of Glasgow |
Occupation | Psychiatrist |
Employer(s) | University College London Royal Free Hospital |
Gill Livingston is a British psychiatrist awho is Professor of Psychiatry of Older People at University College London. Her research involves a life-course analysis of dementia risk and the development of strategies to delay or prevent dementia. She creates evidence-based interventions to improve the lives of people living with dementia and their families.
Livingston's grandmother emigrated from Eastern Europe to Scotland in the early 1900s. Her father was the first in her family to go to university. [1] Livingston studied medicine at the University of Glasgow. She specialised in psychiatry [2] after a placement in Friern Hospital. Livingston became interested in dementia during her work as clinical psychiatrist, where she observed the difference that family carers made to the prognosis of dementia patients. [1] This motivation to specialise in dementia strengthened after watching both her parents struggle with the condition; her father developed progressive supranuclear palsy and dementia in the 2000s and her mother in the 2010s. [1] Her first senior house officer position was at the Royal Free Hospital. [1]
Livingston is an interdisciplinary researcher who combines psychiatry, epidemiological and biopsychosocial enquiry. She was made a professor of Old Age Psychiatry in 2007. [1] Her research investigates new modifiable risk factors for dementia risk, the impact of hearing impairments, and how to help the families of people living with dementia. [3] [4] She led The Lancet Commission on Dementia Prevention, Intervention and Care. [5] She combines new research with meta analysis to develop better understanding of dementia risk. [6] Her research has influenced UK and US policy on dementia risk, and revealed evidence-based interventions that could improve the lives of people with dementia.
Livingston pioneered the STrAtegies for RelaTives (START) programme, an 8 session intervention that helps the carers of people with dementia develop coping strategies. START increases the quality of life and reduces incidence of depression amongst the carers of people living with dementia. [4] She also launched the MARQUE project, a 5-year programme that looked to understand agitation, dementia and how to achieve culture change in care homes. [7] [8] In 2024 she reported that half of dementia cases could be prevented or delayed by addressing various risk factors, [9] [10] particularly high low-density lipoprotein (LDL) or "bad" cholesterol, social isolation and lower levels of education. [11] [12]
Dementia is a syndrome associated with many neurodegenerative diseases, characterized by a general decline in cognitive abilities that affects a person's ability to perform everyday activities. This typically involves problems with memory, thinking, behavior, and motor control. Aside from memory impairment and a disruption in thought patterns, the most common symptoms of dementia include emotional problems, difficulties with language, and decreased motivation. The symptoms may be described as occurring in a continuum over several stages. Dementia ultimately has a significant effect on the individual, their caregivers, and their social relationships in general. A diagnosis of dementia requires the observation of a change from a person's usual mental functioning and a greater cognitive decline than might be caused by the normal aging process.
Derek Summerfield is an honorary senior lecturer at London's Institute of Psychiatry and a member of the Executive Committee of Transcultural Special Interest Group at the Royal College of Psychiatry. He is also an Honorary Fellow of the Egyptian Psychiatric Association. He has published around 150 papers and has made other contributions in medical and social sciences literature.
Viral pneumonia is a pneumonia caused by a virus. Pneumonia is an infection that causes inflammation in one or both lungs. The pulmonary alveoli fill with fluid or pus making it difficult to breathe. Pneumonia can be caused by bacteria, viruses, fungi or parasites. Viruses are the most common cause of pneumonia in children, while in adults bacteria are a more common cause.
The prevention of dementia involves reducing the number of risk factors for the development of dementia, and is a global health priority needing a global response. Initiatives include the establishment of the International Research Network on Dementia Prevention (IRNDP) which aims to link researchers in this field globally, and the establishment of the Global Dementia Observatory a web-based data knowledge and exchange platform, which will collate and disseminate key dementia data from members states. Although there is no cure for dementia, it is well established that modifiable risk factors influence both the likelihood of developing dementia and the age at which it is developed. Dementia can be prevented by reducing the risk factors for vascular disease such as diabetes, high blood pressure, obesity, smoking, physical inactivity and depression. A study concluded that more than a third of dementia cases are theoretically preventable. Among older adults both an unfavorable lifestyle and high genetic risk are independently associated with higher dementia risk. A favorable lifestyle is associated with a lower dementia risk, regardless of genetic risk. In 2020, a study identified 12 modifiable lifestyle factors, and the early treatment of acquired hearing loss was estimated as the most significant of these factors, potentially preventing up to 9% of dementia cases.
International Community for the Relief of Suffering and Starvation (ICROSS) is an international non-governmental organisation that provides health and development services for pastoral communities in East Africa.
Frederick Wabwire-Mangen is a Ugandan physician, public health specialist and medical researcher. Currently he is Professor of Epidemiology and Head of Department of Epidemiology & Biostatistics at Makerere University School of Public Health. Wabwire-Mangen also serves as the Chairman of Council of Kampala International University and a founding member of Accordia Global Health Foundation’s Academic Alliance
Khalida Ismail is Professor of Psychiatry and Medicine at the Institute of Psychiatry, King's College London, specializing in diabetes and mental health. Ismail is an Honorary Consultant Liaison Psychiatrist at King's College Hospital NHS Foundation Trust.
Margaret Mungherera was a senior consultant psychiatrist and medical administrator in Uganda. She served as the president of the Uganda Medical Association re-elected five times and ultimately the World Medical Association from October 2013 until October 2014. She advocated for psychiatric services throughout Uganda, beyond the capital, to improve conditions for Uganda's health-care providers and to get doctors organized in African countries in general.
Clive Ballard is a British, world-leading expert in dementia. He is currently Professor of Age-Related Diseases at the University of Exeter and Interim Deputy Pro-Vice-Chancellor and Dean of the University of Exeter Medical School.
Joy Elizabeth Lawn is a British paediatrician and professor of maternal, reproductive and child health. She is Director of the London School of Hygiene & Tropical Medicine Maternal, Adolescent, Reproductive & Child Health (MARCH) Centre. She developed the epidemiological evidence for the worldwide policy and programming that looks to reduce neonatal deaths and stillbirths and works on large-scale implementation research.
Miia K. Kivipelto is a Finnish neuroscientist and professor at the University of Eastern Finland and Karolinska Institute in Stockholm. Her research focuses on dementia and Alzheimer's disease.
Kimberly A. Powers is an American epidemiologist who is an associate professor of epidemiology at the UNC Gillings School of Global Public Health. She combines epidemiology, statistics and mathematical modelling to understand the transmission of infectious diseases. In 2011 her work on antiretroviral therapy for the management of human immunodeficiency virus was selected by Science as the breakthrough of the year. During the COVID-19 pandemic, Powers looked to understand the spread of SARS-CoV-2.
Peymané Adab is a British physician who is a Professor of Public Health at the University of Birmingham. She leads the Institute of Applied Health Research Chronic Disease Management Team. Adab investigates the epidemiology and management of obesity and chronic obstructive pulmonary disease.
Elisabete Weiderpass-Vainio is a Brazilian cancer researcher who is Director of the International Agency for Research on Cancer, a part of the World Health Organization. Her research considers the epidemiology and prevention of cancer.
Joanne Katz is an epidemiologist, biostatistician, and Professor of International Health at the Johns Hopkins Bloomberg School of Public Health. She holds joint appointments in the Departments of Biostatistics, Epidemiology and Ophthalmology within the School of Medicine. Her expertise is in maternal, neonatal, and child health. She has contributed to the design, conduct and analysis of data from large community-based intervention trials on nutritional and other interventions in Indonesia, Philippines, Bangladesh, Nepal, and other countries.
Felicia Marie Knaul is a British-Canadian health economist who is director of the University of Miami Institute for Advanced Study of the Americas and a professor at the Miller School of Medicine. She is an economist with the Mexican Health Foundation and president of the non-governmental organization Tómatelo a Pecho, an advocacy organisation that promote women's health in Latin America. Her research and leadership has focused around raising awareness of breast cancer in low and middle income countries.
Ashley Adamson is a British dietician, Professor of Public Health Nutrition at Newcastle University. She is director of the National Institute for Health and Care Research School for Public Health Research. Her research looks to understand the relationship between nutrient intake, food choices, socio-demographic characteristics and health outcomes. She was made a NIHR Senior Investigator in 2023.
Rita V. Krishnamurthi is a New Zealand academic, and since 2023 is a full professor at the Auckland University of Technology, specialising in the epidemiology of stroke and dementia.
Mina Fazel is a British psychiatrist who is Professor and Chair of Adolescent Psychiatry in the Department of Psychiatry at the University of Oxford. Her research considers the mental health of children and young people, and how to design effective mental health interventions.
Ruth Bonita, also known as Ruth Bonita Beaglehole, is an Australian–New Zealand academic, and is an emeritus professor at the University of Auckland, specialising in stroke. In 2006 she was appointed an Officer of the New Zealand Order of Merit for services to medicine. She is also an Honorary Doctor of Medicine at Umea University.
{{cite journal}}
: Cite journal requires |journal=
(help)This article needs additional or more specific categories .(January 2025) |